The results showed that IGF2BP3 gene mRNA was highly expressed in most cancer types than in the normal samples, namely, GBM, GBMLGG, LGG, UCEC, CESC, LUAD, COAD, COADREAD, BRCA, ESCA, KIRP, KIPAN, STAD, HNSC, KIRC, LUSC, LIHC, SKCM, OV, PAAD, UCS, LAML, BLCA, ACC, KICH and CHOL, whereas low expression was detected in PRAD and THCA, which was consistent with previous studies in prostate and thyroid cancer (Figure 1) (53–55). Here, IGF2BP3 is linked to thyroid gland carcinoma.